[Inhalational lesions in a patient with severe burns].
Ferre Colomer
M A
MA
Ruiz Gimeno
J I
JI
Femenía Price
F
F
Pelegrín Hidalgo
F
F
D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001993:Bronchodilator Agents / Q000627:therapeutic use; D001999:Bronchoscopy; D002056:Burns / Q000150:complications*; D003131:Combined Modality Therapy; D004280:Dobutamine / Q000627:therapeutic use; D005107:Explosions; D005260:Female; D005440:Fluid Therapy; D015386:Hazardous Substances / Q000009:adverse effects; D006801:Humans; D007442:Intubation, Intratracheal; D009638:Norepinephrine / Q000627:therapeutic use; D010102:Oxygen Inhalation Therapy; D010969:Plastics; D012121:Respiration, Artificial; D012128:Respiratory Distress Syndrome / Q000209:etiology*; D012131:Respiratory Insufficiency / Q000209:etiology; D015208:Smoke Inhalation Injury / Q000097:blood / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy; D014140:Tracheotomy
D000900:Anti-Bacterial Agents; D001993:Bronchodilator Agents; D015386:Hazardous Substances; D010969:Plastics; D004280:Dobutamine; D009638:Norepinephrine